Abbvie Inc v. Medimmune Limited
2:16-cv-00322
Overview
Parties
Defendant
Medimmune Limited NPE (University / Research)
Represented By
0 Attorneys ListedPlaintiff
Court & Judges
Court
District Court, E.D. Virginia (vaed)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° RadarMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US6248516
Single domain ligands, receptors comprising said ligands methods for their production, and use of said ligands and receptors
|
Filed: 1995-06-06
Issued: 2001-06-19
|
Expired (Term Ended)
Expires: 2015-06-06
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
Standard Statutory Term β No obviousness-type double patenting truncation noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
5
Dispositive
1
Granted
0
Denied
0
Pending / Review
5
Motions by Category
Key Dispositive Motions & Rulings